世界の内部神経調節市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Internal Neuromodulation Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3209 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、内部神経調節のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（脊髄刺激、脳深部刺激、迷走神経刺激、仙骨神経刺激、胃電気刺激、その他）、用途別市場規模（疾病治療、研究・開発）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・内部神経調節の市場動向 ・企業の競争状況、市場シェア ・内部神経調節の種類別市場規模（脊髄刺激、脳深部刺激、迷走神経刺激、仙骨神経刺激、胃電気刺激、その他） ・内部神経調節の用途別市場規模（疾病治療、研究・開発） ・内部神経調節の北米市場規模2016-2027（アメリカ、カナダ） ・内部神経調節のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・内部神経調節のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・内部神経調節の中南米市場規模2016-2027（メキシコ、ブラジル） ・内部神経調節の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Medtronic、Boston Scientific Corporation、Abbott、LivaNova、Synapse Biomedical、Nevro Corporation、NeuroSigma、NeuroPace、Neuronetics、BioControl Medical） ・結論

Market Analysis and Insights: Global Internal Neuromodulation Market
The global Internal Neuromodulation market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Internal Neuromodulation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Internal Neuromodulation market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Internal Neuromodulation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Internal Neuromodulation market.

Global Internal Neuromodulation Scope and Market Size
Internal Neuromodulation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Internal Neuromodulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Spinal Cord Stimulation
Deep Brain Stimulation
Vagus Nerve Stimulation
Sacral Nerve Stimulation
Gastric Electrical Stimulation
Others

Segment by Application
Disease Therapy
Research and Development

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Medtronic
Boston Scientific Corporation
Abbott
LivaNova
Synapse Biomedical
Nevro Corporation
NeuroSigma
NeuroPace

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Internal Neuromodulation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Spinal Cord Stimulation
1.2.3 Deep Brain Stimulation
1.2.4 Vagus Nerve Stimulation
1.2.5 Sacral Nerve Stimulation
1.2.6 Gastric Electrical Stimulation
1.2.7 Others
1.3 Market by Application
1.3.1 Global Internal Neuromodulation Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Disease Therapy
1.3.3 Research and Development
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Internal Neuromodulation Market Perspective (2016-2027)
2.2 Internal Neuromodulation Growth Trends by Regions
2.2.1 Internal Neuromodulation Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Internal Neuromodulation Historic Market Share by Regions (2016-2021)
2.2.3 Internal Neuromodulation Forecasted Market Size by Regions (2022-2027)
2.3 Internal Neuromodulation Industry Dynamic
2.3.1 Internal Neuromodulation Market Trends
2.3.2 Internal Neuromodulation Market Drivers
2.3.3 Internal Neuromodulation Market Challenges
2.3.4 Internal Neuromodulation Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Internal Neuromodulation Players by Revenue
3.1.1 Global Top Internal Neuromodulation Players by Revenue (2016-2021)
3.1.2 Global Internal Neuromodulation Revenue Market Share by Players (2016-2021)
3.2 Global Internal Neuromodulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Internal Neuromodulation Revenue
3.4 Global Internal Neuromodulation Market Concentration Ratio
3.4.1 Global Internal Neuromodulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Internal Neuromodulation Revenue in 2020
3.5 Internal Neuromodulation Key Players Head office and Area Served
3.6 Key Players Internal Neuromodulation Product Solution and Service
3.7 Date of Enter into Internal Neuromodulation Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Internal Neuromodulation Breakdown Data by Type
4.1 Global Internal Neuromodulation Historic Market Size by Type (2016-2021)
4.2 Global Internal Neuromodulation Forecasted Market Size by Type (2022-2027)

5 Internal Neuromodulation Breakdown Data by Application
5.1 Global Internal Neuromodulation Historic Market Size by Application (2016-2021)
5.2 Global Internal Neuromodulation Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Internal Neuromodulation Market Size (2016-2027)
6.2 North America Internal Neuromodulation Market Size by Type
6.2.1 North America Internal Neuromodulation Market Size by Type (2016-2021)
6.2.2 North America Internal Neuromodulation Market Size by Type (2022-2027)
6.2.3 North America Internal Neuromodulation Market Size by Type (2016-2027)
6.3 North America Internal Neuromodulation Market Size by Application
6.3.1 North America Internal Neuromodulation Market Size by Application (2016-2021)
6.3.2 North America Internal Neuromodulation Market Size by Application (2022-2027)
6.3.3 North America Internal Neuromodulation Market Size by Application (2016-2027)
6.4 North America Internal Neuromodulation Market Size by Country
6.4.1 North America Internal Neuromodulation Market Size by Country (2016-2021)
6.4.2 North America Internal Neuromodulation Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Internal Neuromodulation Market Size (2016-2027)
7.2 Europe Internal Neuromodulation Market Size by Type
7.2.1 Europe Internal Neuromodulation Market Size by Type (2016-2021)
7.2.2 Europe Internal Neuromodulation Market Size by Type (2022-2027)
7.2.3 Europe Internal Neuromodulation Market Size by Type (2016-2027)
7.3 Europe Internal Neuromodulation Market Size by Application
7.3.1 Europe Internal Neuromodulation Market Size by Application (2016-2021)
7.3.2 Europe Internal Neuromodulation Market Size by Application (2022-2027)
7.3.3 Europe Internal Neuromodulation Market Size by Application (2016-2027)
7.4 Europe Internal Neuromodulation Market Size by Country
7.4.1 Europe Internal Neuromodulation Market Size by Country (2016-2021)
7.4.2 Europe Internal Neuromodulation Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Internal Neuromodulation Market Size (2016-2027)
8.2 Asia-Pacific Internal Neuromodulation Market Size by Type
8.2.1 Asia-Pacific Internal Neuromodulation Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Internal Neuromodulation Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Internal Neuromodulation Market Size by Type (2016-2027)
8.3 Asia-Pacific Internal Neuromodulation Market Size by Application
8.3.1 Asia-Pacific Internal Neuromodulation Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Internal Neuromodulation Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Internal Neuromodulation Market Size by Application (2016-2027)
8.4 Asia-Pacific Internal Neuromodulation Market Size by Region
8.4.1 Asia-Pacific Internal Neuromodulation Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Internal Neuromodulation Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Internal Neuromodulation Market Size (2016-2027)
9.2 Latin America Internal Neuromodulation Market Size by Type
9.2.1 Latin America Internal Neuromodulation Market Size by Type (2016-2021)
9.2.2 Latin America Internal Neuromodulation Market Size by Type (2022-2027)
9.2.3 Latin America Internal Neuromodulation Market Size by Type (2016-2027)
9.3 Latin America Internal Neuromodulation Market Size by Application
9.3.1 Latin America Internal Neuromodulation Market Size by Application (2016-2021)
9.3.2 Latin America Internal Neuromodulation Market Size by Application (2022-2027)
9.3.3 Latin America Internal Neuromodulation Market Size by Application (2016-2027)
9.4 Latin America Internal Neuromodulation Market Size by Country
9.4.1 Latin America Internal Neuromodulation Market Size by Country (2016-2021)
9.4.2 Latin America Internal Neuromodulation Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Internal Neuromodulation Market Size (2016-2027)
10.2 Middle East & Africa Internal Neuromodulation Market Size by Type
10.2.1 Middle East & Africa Internal Neuromodulation Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Internal Neuromodulation Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Internal Neuromodulation Market Size by Type (2016-2027)
10.3 Middle East & Africa Internal Neuromodulation Market Size by Application
10.3.1 Middle East & Africa Internal Neuromodulation Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Internal Neuromodulation Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Internal Neuromodulation Market Size by Application (2016-2027)
10.4 Middle East & Africa Internal Neuromodulation Market Size by Country
10.4.1 Middle East & Africa Internal Neuromodulation Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Internal Neuromodulation Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Internal Neuromodulation Introduction
11.1.4 Medtronic Revenue in Internal Neuromodulation Business (2016-2021)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Details
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation Internal Neuromodulation Introduction
11.2.4 Boston Scientific Corporation Revenue in Internal Neuromodulation Business (2016-2021)
11.2.5 Boston Scientific Corporation Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Internal Neuromodulation Introduction
11.3.4 Abbott Revenue in Internal Neuromodulation Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 LivaNova
11.4.1 LivaNova Company Details
11.4.2 LivaNova Business Overview
11.4.3 LivaNova Internal Neuromodulation Introduction
11.4.4 LivaNova Revenue in Internal Neuromodulation Business (2016-2021)
11.4.5 LivaNova Recent Development
11.5 Synapse Biomedical
11.5.1 Synapse Biomedical Company Details
11.5.2 Synapse Biomedical Business Overview
11.5.3 Synapse Biomedical Internal Neuromodulation Introduction
11.5.4 Synapse Biomedical Revenue in Internal Neuromodulation Business (2016-2021)
11.5.5 Synapse Biomedical Recent Development
11.6 Nevro Corporation
11.6.1 Nevro Corporation Company Details
11.6.2 Nevro Corporation Business Overview
11.6.3 Nevro Corporation Internal Neuromodulation Introduction
11.6.4 Nevro Corporation Revenue in Internal Neuromodulation Business (2016-2021)
11.6.5 Nevro Corporation Recent Development
11.7 NeuroSigma
11.7.1 NeuroSigma Company Details
11.7.2 NeuroSigma Business Overview
11.7.3 NeuroSigma Internal Neuromodulation Introduction
11.7.4 NeuroSigma Revenue in Internal Neuromodulation Business (2016-2021)
11.7.5 NeuroSigma Recent Development
11.8 NeuroPace
11.8.1 NeuroPace Company Details
11.8.2 NeuroPace Business Overview
11.8.3 NeuroPace Internal Neuromodulation Introduction
11.8.4 NeuroPace Revenue in Internal Neuromodulation Business (2016-2021)
11.8.5 NeuroPace Recent Development
11.9 Neuronetics
11.9.1 Neuronetics Company Details
11.9.2 Neuronetics Business Overview
11.9.3 Neuronetics Internal Neuromodulation Introduction
11.9.4 Neuronetics Revenue in Internal Neuromodulation Business (2016-2021)
11.9.5 Neuronetics Recent Development
11.10 BioControl Medical
11.10.1 BioControl Medical Company Details
11.10.2 BioControl Medical Business Overview
11.10.3 BioControl Medical Internal Neuromodulation Introduction
11.10.4 BioControl Medical Revenue in Internal Neuromodulation Business (2016-2021)
11.10.5 BioControl Medical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Internal Neuromodulation Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Spinal Cord Stimulation
Table 3. Key Players of Deep Brain Stimulation
Table 4. Key Players of Vagus Nerve Stimulation
Table 5. Key Players of Sacral Nerve Stimulation
Table 6. Key Players of Gastric Electrical Stimulation
Table 7. Key Players of Others
Table 8. Global Internal Neuromodulation Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Internal Neuromodulation Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Internal Neuromodulation Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Internal Neuromodulation Market Share by Regions (2016-2021)
Table 12. Global Internal Neuromodulation Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Internal Neuromodulation Market Share by Regions (2022-2027)
Table 14. Internal Neuromodulation Market Trends
Table 15. Internal Neuromodulation Market Drivers
Table 16. Internal Neuromodulation Market Challenges
Table 17. Internal Neuromodulation Market Restraints
Table 18. Global Internal Neuromodulation Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Internal Neuromodulation Market Share by Players (2016-2021)
Table 20. Global Top Internal Neuromodulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Internal Neuromodulation as of 2020)
Table 21. Ranking of Global Top Internal Neuromodulation Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Internal Neuromodulation Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Internal Neuromodulation Product Solution and Service
Table 25. Date of Enter into Internal Neuromodulation Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Internal Neuromodulation Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Internal Neuromodulation Revenue Market Share by Type (2016-2021)
Table 29. Global Internal Neuromodulation Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Internal Neuromodulation Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Internal Neuromodulation Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Internal Neuromodulation Revenue Market Share by Application (2016-2021)
Table 33. Global Internal Neuromodulation Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Internal Neuromodulation Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Internal Neuromodulation Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Internal Neuromodulation Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Internal Neuromodulation Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Internal Neuromodulation Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Internal Neuromodulation Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Internal Neuromodulation Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Internal Neuromodulation Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Internal Neuromodulation Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Internal Neuromodulation Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Internal Neuromodulation Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Internal Neuromodulation Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Internal Neuromodulation Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Internal Neuromodulation Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Internal Neuromodulation Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Internal Neuromodulation Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Internal Neuromodulation Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Internal Neuromodulation Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Internal Neuromodulation Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Internal Neuromodulation Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Internal Neuromodulation Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Internal Neuromodulation Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Internal Neuromodulation Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Internal Neuromodulation Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Internal Neuromodulation Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Internal Neuromodulation Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Internal Neuromodulation Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Internal Neuromodulation Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Internal Neuromodulation Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Internal Neuromodulation Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Internal Neuromodulation Market Size by Country (2022-2027) & (US$ Million)
Table 65. Medtronic Company Details
Table 66. Medtronic Business Overview
Table 67. Medtronic Internal Neuromodulation Product
Table 68. Medtronic Revenue in Internal Neuromodulation Business (2016-2021) & (US$ Million)
Table 69. Medtronic Recent Development
Table 70. Boston Scientific Corporation Company Details
Table 71. Boston Scientific Corporation Business Overview
Table 72. Boston Scientific Corporation Internal Neuromodulation Product
Table 73. Boston Scientific Corporation Revenue in Internal Neuromodulation Business (2016-2021) & (US$ Million)
Table 74. Boston Scientific Corporation Recent Development
Table 75. Abbott Company Details
Table 76. Abbott Business Overview
Table 77. Abbott Internal Neuromodulation Product
Table 78. Abbott Revenue in Internal Neuromodulation Business (2016-2021) & (US$ Million)
Table 79. Abbott Recent Development
Table 80. LivaNova Company Details
Table 81. LivaNova Business Overview
Table 82. LivaNova Internal Neuromodulation Product
Table 83. LivaNova Revenue in Internal Neuromodulation Business (2016-2021) & (US$ Million)
Table 84. LivaNova Recent Development
Table 85. Synapse Biomedical Company Details
Table 86. Synapse Biomedical Business Overview
Table 87. Synapse Biomedical Internal Neuromodulation Product
Table 88. Synapse Biomedical Revenue in Internal Neuromodulation Business (2016-2021) & (US$ Million)
Table 89. Synapse Biomedical Recent Development
Table 90. Nevro Corporation Company Details
Table 91. Nevro Corporation Business Overview
Table 92. Nevro Corporation Internal Neuromodulation Product
Table 93. Nevro Corporation Revenue in Internal Neuromodulation Business (2016-2021) & (US$ Million)
Table 94. Nevro Corporation Recent Development
Table 95. NeuroSigma Company Details
Table 96. NeuroSigma Business Overview
Table 97. NeuroSigma Internal Neuromodulation Product
Table 98. NeuroSigma Revenue in Internal Neuromodulation Business (2016-2021) & (US$ Million)
Table 99. NeuroSigma Recent Development
Table 100. NeuroPace Company Details
Table 101. NeuroPace Business Overview
Table 102. NeuroPace Revenue in Internal Neuromodulation Business (2016-2021) & (US$ Million)
Table 103. NeuroPace Recent Development
Table 104. Neuronetics Company Details
Table 105. Neuronetics Business Overview
Table 106. Neuronetics Internal Neuromodulation Product
Table 107. Neuronetics Revenue in Internal Neuromodulation Business (2016-2021) & (US$ Million)
Table 108. Neuronetics Recent Development
Table 109. BioControl Medical Company Details
Table 110. BioControl Medical Business Overview
Table 111. BioControl Medical Internal Neuromodulation Product
Table 112. BioControl Medical Revenue in Internal Neuromodulation Business (2016-2021) & (US$ Million)
Table 113. BioControl Medical Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Internal Neuromodulation Market Share by Type: 2020 VS 2027
Figure 2. Spinal Cord Stimulation Features
Figure 3. Deep Brain Stimulation Features
Figure 4. Vagus Nerve Stimulation Features
Figure 5. Sacral Nerve Stimulation Features
Figure 6. Gastric Electrical Stimulation Features
Figure 7. Others Features
Figure 8. Global Internal Neuromodulation Market Share by Application: 2020 VS 2027
Figure 9. Disease Therapy Case Studies
Figure 10. Research and Development Case Studies
Figure 11. Internal Neuromodulation Report Years Considered
Figure 12. Global Internal Neuromodulation Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Internal Neuromodulation Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Internal Neuromodulation Market Share by Regions: 2020 VS 2027
Figure 15. Global Internal Neuromodulation Market Share by Regions (2022-2027)
Figure 16. Global Internal Neuromodulation Market Share by Players in 2020
Figure 17. Global Top Internal Neuromodulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Internal Neuromodulation as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Internal Neuromodulation Revenue in 2020
Figure 19. Global Internal Neuromodulation Revenue Market Share by Type (2016-2021)
Figure 20. Global Internal Neuromodulation Revenue Market Share by Type (2022-2027)
Figure 21. North America Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Internal Neuromodulation Market Share by Type (2016-2027)
Figure 23. North America Internal Neuromodulation Market Share by Application (2016-2027)
Figure 24. North America Internal Neuromodulation Market Share by Country (2016-2027)
Figure 25. United States Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Internal Neuromodulation Market Share by Type (2016-2027)
Figure 29. Europe Internal Neuromodulation Market Share by Application (2016-2027)
Figure 30. Europe Internal Neuromodulation Market Share by Country (2016-2027)
Figure 31. Germany Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Internal Neuromodulation Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Internal Neuromodulation Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Internal Neuromodulation Market Share by Region (2016-2027)
Figure 41. China Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Internal Neuromodulation Market Share by Type (2016-2027)
Figure 49. Latin America Internal Neuromodulation Market Share by Application (2016-2027)
Figure 50. Latin America Internal Neuromodulation Market Share by Country (2016-2027)
Figure 51. Mexico Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Internal Neuromodulation Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Internal Neuromodulation Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Internal Neuromodulation Market Share by Country (2016-2027)
Figure 57. Turkey Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Internal Neuromodulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Medtronic Revenue Growth Rate in Internal Neuromodulation Business (2016-2021)
Figure 61. Boston Scientific Corporation Revenue Growth Rate in Internal Neuromodulation Business (2016-2021)
Figure 62. Abbott Revenue Growth Rate in Internal Neuromodulation Business (2016-2021)
Figure 63. LivaNova Revenue Growth Rate in Internal Neuromodulation Business (2016-2021)
Figure 64. Synapse Biomedical Revenue Growth Rate in Internal Neuromodulation Business (2016-2021)
Figure 65. Nevro Corporation Revenue Growth Rate in Internal Neuromodulation Business (2016-2021)
Figure 66. NeuroSigma Revenue Growth Rate in Internal Neuromodulation Business (2016-2021)
Figure 67. NeuroPace Revenue Growth Rate in Internal Neuromodulation Business (2016-2021)
Figure 68. Neuronetics Revenue Growth Rate in Internal Neuromodulation Business (2016-2021)
Figure 69. BioControl Medical Revenue Growth Rate in Internal Neuromodulation Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---